IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2025 Holdings

Filed 2025-05-15 | 7 holdings | $154.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$51.1M2,816,02233.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$34.2M309,11622.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$24.1M600,00015.6%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$24.1M16,390,00015.6%
Amarin Corp PLCSPONS ADR NEW023111206$11.1M24,850,6237.2%
Lantheus Hldgs Inc(LNTH)COM516544103$9.8M100,0006.3%
VOR Biopharma IncCOM929033108$364.5K508,0160.2%